Key Takeaway: The distinction between research-grade and pharmaceutical-grade peptides represents a critical safety consideration
With age, TLs in hematopoietic stem/progenitor cells become progressively shorter, gradually approaching a telomere brink, i.e., critically short TLs thereby compromising the function of these cells and increasing the risk of death in the near future (Steenstrup et al., 2017
NIDDK-Tirzepatide offers cardiovascular protection by reducing the risk of heart disease
Some lipotropic B12 injections contain phentermine
through body weight loss and improvement of body composition, has the potential to reduce the risk of heart disease, diabetes, and stroke in people with overweight or obesity, according to the lead researcher
Diabetes Research and Clinical Practice, 203, 110881